Monthly News Roundup - April 2018

Jynarque is First Approved Drug for Serious Genetic Kidney Disease The U.S. Food and Drug Administration (FDA) has approved Otsuka’s Jynarque (tolvaptan), a selective vasopressin V2-receptor antagonist, as the first medicine to slow kidney...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news